期刊
GENETICS AND MOLECULAR RESEARCH
卷 10, 期 4, 页码 2671-2678出版社
FUNPEC-EDITORA
DOI: 10.4238/2011.October.31.18
关键词
Granulocyte colony-stimulating factor; Synthetic cDNA; Recombinant G-CSF; Cloning; Gene expression
资金
- Center of Excellence in Biotechnology Research, College of Sciences, King Saud University, Riyadh, Saudi Arabia
Recently, granulocyte colony-stimulating factor (GCSF) has been recognized as a useful molecule for the treatment of a wide range of complex ailments, such as cancer, AIDS, H1N1 influenza, cardiac and neurological diseases. The vast therapeutic potential of G-CSF has induced scientists to develop biotechnological approaches for the synthesis of this pharmacologically active agent. We used a synthetic G-CSF cDNA molecule to produce the target protein by a simple cloning protocol. We constructed the synthetic cDNA using a DNA synthesizer with the aim to increase its expression level by specific sequence modifications at the 5' end of the G-CSF-coding region, decreasing the GC content without altering the predicted amino acid sequences. The identity of the resulting protein was confirmed by a highly specific enzyme-linked immunosorbent assay. In conclusion, a synthetic G-CSF cDNA in combination with the recombinant DNA protocol offers a rapid and reliable strategy for synthesizing the target protein. However, commercial utilization of this methodology will require rigorous validation and quality control.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据